Lux Health Tech Acquisition Corp. (NASDAQ:LUXA) announced this afternoon that it will not consummate a business combination and will instead dissolve and liquidate its trust, effective as of the close of business on October 29.
Lux Health Tech’s liquidation comes just a month after it had signed a non-binding letter of intent (LOI) to combine with an unnamed leading life sciences company. Little else was disclosed in that press release regarding the transaction, but the healthcare-focused SPAC expected to announce further information once the agreement was executed, which was expected to occur in the second half of 2022.
Following the close of business, public shares of LUXA will be deemed cancelled and will represent only the right to receive the redemption amount of $10.04. The SPAC raised $300 million in its October 2020 IPO and originally aimed to combine with a healthcare technology target with an experienced management team of serial entrepreneurs and acclaimed scientists.
As a result of the liquidation, Lux Health Tech has cancelled its special meeting for shareholders on October 13. The management team did not comment on the difficulties of its target search, but a handful of SPACs have recently noted that a challenging environment of high redemptions as well as a potential excise tax on redemptions have caused teams to liquidate.
Lux Health Tech is now the 33rd SPAC to announce its intention to liquidate in 2022.


Terms Tracker for the Week Ending July 3, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re heading into the July 4th holiday, so we’ll keep this week’s column short and to the point. But before you head to the beach,...
Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...
At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....